DATA GRAPHICS | Data Byte
Distillery spotlight on Italian innovation
Opportunities include compounds and targets for cancer, neurology and musculoskeletal diseases, and discoveries from company founders
May 13, 2022 5:04 PM UTC
Italian researchers with papers captured in BioCentury’s Distillery include company founders working on microbial metabolites, amyloid aggregation, diabetes mechanisms and retinal gene therapies.
BioCentury’s Distillery, a curated collection of translational studies from more than 25 journals, provides summaries of preclinical papers that showcase targets and technologies with disease-modifying effects. ...